T. Casagrande

Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study

A. Teixeira-Carvalho, D. Pereira, V. Valim, 2020, Frontiers in Immunology.

Serum biomarker profile orchestrating the seroconversion status of patients with autoimmune diseases upon planned primary 17DD Yellow fever vaccination

A. Teixeira-Carvalho, V. Valim, É. Serrano, 2021, Scientific reports.

Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis.

A. Teixeira-Carvalho, V. Valim, O. Martins-Filho, 2022, Vaccine.